Ginkgo Bioworks Holdings (DNA) Total Debt (2020 - 2021)
Ginkgo Bioworks Holdings' (DNA) quarterly Total Debt came in at $631638.0 in Q2 2021, up 110.55% quarter-over-quarter from $300000.0 in Q4 2020.
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Total Debt (2020 - 2021) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Total Debt for 2 consecutive years, with $631638.0 the latest figure, recorded in Q2 2021.
- For the quarter ending Q2 2021, Total Debt changed N/A year-over-year to $631638.0; the trailing twelve-month figure through Jun 2021 stood at $631638.0 (changed N/A YoY), and the FY2020 full-year result was $300000.0, changed N/A from the prior year.
- Total Debt climbed to $631638.0 in Q2 2021 per DNA's latest filing, from $300000.0 in the prior quarter.
- Across five years, Total Debt topped out at $631638.0 in Q2 2021 and bottomed at $300000.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 16.00 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 2.62 Bn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 3.39 Bn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 1.05 Bn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | 553.13 Mn |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | - |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |